SMTL ID : 8qjt.1 (2 other biounits)

BRM (SMARCA2) Bromodomain in complex with ligand 10

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.57 Å

Oligo State

monomer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 2 residues within 4Å: Chain A: E.47 Ligands: VLC.3 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:E.47 ZN.2: 1 residues within 4Å: Chain A: H.71 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:H.71

1 x VLC: 2-[6-azanyl-5-[(1R,5S)-8-[2-(2-methoxyethoxy)pyridin-4-yl]-3,8-diazabicyclo[3.2.1]octan-3-yl]pyridazin-3-yl]phenol(Non-covalent)

VLC.3: 15 residues within 4Å: Chain A: V.38, F.39, Q.41, L.42, P.43, E.47, L.48, Y.51, V.59, D.60, A.90, F.93, N.94, I.100 Ligands: ZN.1 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:V.38, A:L.42, A:D.60 Hydrogen bonds: A:N.94, A:N.94 pi-Stacking: A:F.39

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Berlin, M. et al., PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models. J.Med.Chem. (2024)

Release Date

2024-01-17

Peptides

Probable global transcription activator SNF2L2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Probable global transcription activator SNF2L2

Related Entries With Identical Sequence